Over the past year, many Cencora, Inc. ( NYSE:COR ) insiders sold a significant stake in the company which may have... CONSHOHOCKEN, Pa., February 07, 2025--Cencora, Inc. (NYSE: COR) today ...
Cencora (NYSE:COR) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table summarizes their recent ratings, shedding ...
Hello and welcome everyone to the Cencora Q1 fiscal year 2025 earnings call. My name is Becky and I’ll be your Operator today. During the presentation, you can register a question by pressing ...
Hosted on MSN1mon
Cencora's Quarterly Earnings Preview: What You Need to KnowCencora, Inc. (COR), headquartered in Pennsylvania, is a global pharmaceutical sourcing and distribution leader offering innovative healthcare solutions and services. With a market cap of $45.2 ...
CONSHOHOCKEN, Pa. — CONSHOHOCKEN, Pa. — Cencora, Inc. (COR) on Wednesday reported fiscal first-quarter net income of $488.6 million. The Conshohocken, Pennsylvania-based company said it had ...
Mauch emphasized the strategic alignment of the RCA acquisition with Cencora’s pharmaceutical-centric strategy. CFO James Cleary noted, "Cencora delivered strong results in the first quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback